Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-16

Clinical Trial Update: A Novel Compound for Alcoholism Treatment: A Translational Strategy - Part II [Phase 2]

View source ↗

Summary

Phase 2 translational trial update for a novel compound targeting alcoholism; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Alcoholism | Phase 2 | Status: TERMINATED | Results posted: 2022-03-16